您的位置: 首页 > 农业专利 > 详情页

COMPOSITIONS LYOPHILISÉES À SURFACE SPÉCIFIQUE ÉLEVÉE COMPRENANT DE L'ARSENIC DESTINÉES À UNE ADMINISTRATION ORALE CHEZ DES PATIENTS
专利权人:
Orsenix Holdings BV
发明人:
VADDI, Krishna,KURUMADDALI, Kumar
申请号:
EP16744263
公开号:
EP3250214A4
申请日:
2016.02.01
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
The present invention relates to treating malignancies such as tumors or cancers by orally administering lyophilized compositions comprising arsenic to a subject in such need. Malignancies include various hematological malignancies, such as acute myeloid leukemia (AML) including acute promyelocytic leukemia (APL), myelodysplastic syndrome (MDS), multiple myeloma (MM) and lymphomas and solid tumors including glioblastoma multiforme and breast cancer. Arsenic treatment has shown great promise in the treatment of several cancers but requires daily intravenous (IV) administration. This invention relates to a novel formulation comprising a lyophilized compositions comprising arsenic. As a result, the formulation facilitates a systemic bioavailability comparable to that of intravenous (IV) administration of arsenic trioxide currently practiced. The present invention also relates to a method for lyophilizing the arsenic trioxide, preparing the oral formulation comprising lyophilized compositions comprising arsenic, and a method for treating a subject with malignancies using the oral formulation.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充